MCID: FBR003
MIFTS: 45

Fibrous Histiocytoma

Categories: Cancer diseases, Skin diseases

Aliases & Classifications for Fibrous Histiocytoma

MalaCards integrated aliases for Fibrous Histiocytoma:

Name: Fibrous Histiocytoma 12 15
Histiocytoma, Benign Fibrous 44 73
Benign Fibrous Histiocytoma 12
Histiocytoma Fibrous 55
Fibroxanthoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4415
MeSH 44 D018219
NCIt 50 C3739
SNOMED-CT 68 25889007
UMLS 73 C0206644

Summaries for Fibrous Histiocytoma

MalaCards based summary : Fibrous Histiocytoma, also known as histiocytoma, benign fibrous, is related to cutaneous fibrous histiocytoma and malignant fibroxanthoma. An important gene associated with Fibrous Histiocytoma is ATF1 (Activating Transcription Factor 1), and among its related pathways/superpathways are Transcriptional misregulation in cancer and Striated Muscle Contraction. The drugs Mechlorethamine and Ifosfamide have been mentioned in the context of this disorder. Affiliated tissues include bone, skin and lung.

Wikipedia : 76 Benign fibrous histiocytomas (also known as dermal dendrocytoma,dermatofibroma,fibrous... more...

Related Diseases for Fibrous Histiocytoma

Diseases related to Fibrous Histiocytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 290)
# Related Disease Score Top Affiliating Genes
1 cutaneous fibrous histiocytoma 33.3 ACTC1 DES F13A1 S100B SERPINA3 VIM
2 malignant fibroxanthoma 32.9 ACTC1 DES F13A1 S100B SERPINA3 VIM
3 myxofibrosarcoma 32.5 DES FUS S100B
4 histiocytoma 31.8 ATF1 CD163 CREB1 EWSR1 FUS MFHAS1
5 sarcoma 31.2 ATF1 EWSR1 FUS MTAP
6 liposarcoma 30.6 DES EWSR1 FUS VIM
7 leiomyosarcoma 30.3 ACTC1 DES S100B VIM
8 dedifferentiated liposarcoma 30.3 ACTC1 DES
9 chordoma 30.1 DES MTAP S100B VIM
10 pleomorphic liposarcoma 30.1 DES S100B VIM
11 granuloma annulare 30.1 F13A1 VIM
12 syringocystadenoma papilliferum 30.1 DES S100B VIM
13 myxoid liposarcoma 30.0 ATF1 EWSR1 FUS
14 congenital fibrosarcoma 30.0 ACTC1 DES VIM
15 histiocytosis 30.0 CD163 S100B SERPINA3
16 spindle cell carcinoma 30.0 ACTC1 DES VIM
17 embryonal sarcoma 30.0 DES S100B SERPINA3 VIM
18 perineurioma 29.9 S100B VIM
19 lentigo maligna melanoma 29.9 MITF S100B
20 leiomyoma 29.8 ACTC1 DES VIM
21 fibromatosis 29.8 ACTC1 DES VIM
22 giant cell tumor 29.8 ACTC1 DES SERPINA3 VIM
23 langerhans cell histiocytosis 29.8 CD163 F13A1 S100B
24 carcinosarcoma 29.8 ACTC1 DES VIM
25 spindle cell sarcoma 29.8 ACTC1 DES S100B VIM
26 dermatofibrosarcoma protuberans 29.7 ACTC1 DES F13A1 S100B SERPINA3 VIM
27 gliosarcoma 29.7 ACTC1 S100B VIM
28 rhabdomyosarcoma 29.6 ACTC1 DES EWSR1 VIM
29 granular cell tumor 29.6 DES S100B SERPINA3 VIM
30 inflammatory myofibroblastic tumor 29.5 ACTC1 DES S100B VIM
31 hemangiopericytoma, malignant 29.3 ACTC1 DES F13A1 S100B VIM
32 diaphyseal medullary stenosis with malignant fibrous histiocytoma 12.9
33 malignant fibrous histiocytoma of bone 12.5
34 malignant skin fibrous histiocytoma 12.4
35 histiocytoma, angiomatoid fibrous 12.4
36 undifferentiated pleomorphic sarcoma 12.3
37 benign deep fibrous histiocytoma 12.3
38 sclerosing hemangioma 12.1
39 tenosynovial giant cell tumor 11.7
40 pigmented villonodular synovitis 11.3
41 urachal cancer 11.2
42 fibrosarcoma 10.4
43 squamous cell carcinoma 10.4
44 xeroderma pigmentosum, variant type 10.3
45 burn scar 10.3
46 lymphoma 10.3
47 osteomyelitis 10.3
48 intussusception 10.2
49 fibrous dysplasia 10.2
50 melanoma 10.2

Graphical network of the top 20 diseases related to Fibrous Histiocytoma:



Diseases related to Fibrous Histiocytoma

Symptoms & Phenotypes for Fibrous Histiocytoma

Drugs & Therapeutics for Fibrous Histiocytoma

Drugs for Fibrous Histiocytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 97)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Mechlorethamine Approved, Investigational Phase 3,Phase 2,Phase 1,Not Applicable 51-75-2 4033
2
Ifosfamide Approved Phase 3,Phase 2,Phase 1,Not Applicable 3778-73-2 3690
3
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1,Not Applicable 23214-92-8 31703
4
Carboplatin Approved Phase 3 41575-94-4 10339178 38904 498142
5
Dactinomycin Approved, Investigational Phase 3 50-76-0 457193 2019
6
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
7
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 6055-19-2, 50-18-0 2907
8
Vincristine Approved, Investigational Phase 3 57-22-7, 2068-78-2 5978
9
Epirubicin Approved Phase 3 56420-45-2 41867
10
Lenograstim Approved, Investigational Phase 3 135968-09-1
11
Trabectedin Approved, Investigational Phase 2, Phase 3 114899-77-3 108150
12
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1,Not Applicable 31703
13
Isophosphamide mustard Phase 3,Phase 2,Phase 1,Not Applicable 0
14 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1,Not Applicable
15 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1,Not Applicable
16 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1,Not Applicable
17 Alkylating Agents Phase 3,Phase 2,Phase 1,Not Applicable
18 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1,Not Applicable
19 Anti-Infective Agents Phase 3,Phase 2,Phase 1
20 Antineoplastic Agents, Phytogenic Phase 3,Phase 2
21 Immunologic Factors Phase 3,Phase 1,Phase 2
22 Etoposide phosphate Phase 3,Phase 2
23 Antimitotic Agents Phase 3,Phase 2
24 Antirheumatic Agents Phase 3,Phase 2,Phase 1
25 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
26 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
27
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
28
Indinavir Approved Phase 2 150378-17-9 5362440
29
Dacarbazine Approved, Investigational Phase 2 4342-03-4 5351166
30
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
31
Sunitinib Approved, Investigational Phase 2 557795-19-4, 341031-54-7 5329102
32
Bevacizumab Approved, Investigational Phase 2 216974-75-3
33
Nicotinamide Approved, Investigational Phase 2 98-92-0 936
34
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
35
Romidepsin Approved, Investigational Phase 2 128517-07-7 5352062
36
Sirolimus Approved, Investigational Phase 1, Phase 2 53123-88-9 46835353 6436030 5284616
37
Everolimus Approved Phase 1, Phase 2 159351-69-6 6442177
38
Miconazole Approved, Investigational, Vet_approved Phase 1, Phase 2 22916-47-8 4189
39
Dasatinib Approved, Investigational Phase 2 302962-49-8 3062316
40
Cisplatin Approved Phase 2 15663-27-1 2767 441203 84093
41
leucovorin Approved Phase 2 58-05-9 6006 143
42
Methotrexate Approved Phase 2 59-05-2, 1959-05-2 126941
43
Gemcitabine Approved Phase 2 95058-81-4 60750
44
Paclitaxel Approved, Vet_approved Phase 2 33069-62-4 36314
45
Niacin Approved, Investigational, Nutraceutical Phase 2 59-67-6 938
46
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
47
Saracatinib Investigational Phase 2 379231-04-6
48 Soblidotin Investigational Phase 2 149606-27-9
49 Exatecan Investigational Phase 2 171335-80-1
50
Camptothecin Experimental Phase 2 7689-03-4

Interventional clinical trials:

(show all 47)
# Name Status NCT ID Phase Drugs
1 Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Unknown status NCT00334854 Phase 3 doxorubicin hydrochloride;ifosfamide
2 Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma Unknown status NCT01344018 Phase 3
3 Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
4 Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00346164 Phase 3 doxorubicin hydrochloride;ifosfamide
5 Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis Completed NCT00091351 Phase 3
6 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
7 Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3 doxorubicin hydrochloride;ifosfamide
8 Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00061984 Phase 3 doxorubicin hydrochloride;ifosfamide
9 Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00003052 Phase 3 doxorubicin hydrochloride;etoposide;ifosfamide
10 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
11 Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma Active, not recruiting NCT00423618 Phase 3
12 Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Suspended NCT02180867 Phase 2, Phase 3 Doxorubicin Hydrochloride;Ifosfamide;Pazopanib Hydrochloride
13 Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Terminated NCT01189253 Phase 2, Phase 3 doxorubicin hydrochloride;trabectedin
14 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
15 Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma Unknown status NCT00410462 Phase 2 brostallicin;doxorubicin hydrochloride
16 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Unknown status NCT00003718 Phase 2 temozolomide
17 Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma Completed NCT00400569 Phase 2 Sunitinib Malate (SU011248)
18 Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma Completed NCT00031915 Phase 2 imatinib mesylate
19 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
20 Bevacizumab and Radiation Therapy for Sarcomas Completed NCT00356031 Phase 2 Bevacizumab
21 Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung Completed NCT00503295 Phase 2
22 Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma Completed NCT00085475 Phase 2 imatinib mesylate
23 AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00659360 Phase 2 saracatinib
24 Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma Completed NCT00245102 Phase 2 sorafenib tosylate
25 Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Completed NCT00112463 Phase 2 romidepsin
26 Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma Completed NCT00949325 Phase 1, Phase 2 temsirolimus (Torisel) plus liposomal doxorubicin (Doxil)
27 Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00064220 Phase 2 soblidotin
28 BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors Completed NCT00526149 Phase 2 BI 2536
29 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00003939 Phase 2 trabectedin
30 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2 imatinib mesylate
31 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma Completed NCT00053794 Phase 2 perifosine
32 Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00041249 Phase 2 brostallicin
33 Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00041236 Phase 2 exatecan mesylate
34 Trial of Dasatinib in Advanced Sarcomas Completed NCT00464620 Phase 2 Dasatinib
35 A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma Active, not recruiting NCT00667342 Phase 2 Cisplatin;Doxorubicin;Methotrexate;Ifosfamide;etoposide
36 Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers Active, not recruiting NCT02392637 Phase 2 Abraxane (Nab-Paclitaxel);Cisplatin;Gemcitabine
37 Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma Terminated NCT00740597 Phase 2
38 Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Completed NCT00450736 Phase 1 celecoxib
39 Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00030784 Phase 1 ifosfamide;pegylated liposomal doxorubicin hydrochloride
40 Vaccine Therapy in Treating Patients With Metastatic Cancer Completed NCT00020267 Phase 1 interleukin-2;MAGE-12 peptide vaccine;Montanide ISA-51
41 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
42 Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX Unknown status NCT00900211
43 Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone Completed NCT00007046
44 Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy Completed NCT01674101 Not Applicable
45 PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma Active, not recruiting NCT00346125 Not Applicable doxorubicin hydrochloride;ifosfamide;pegylated liposomal doxorubicin hydrochloride
46 Angiomatoid Fibrous Histiocytoma: a Single Institution Case-series Not yet recruiting NCT03759327
47 Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma Withdrawn NCT00334984 Not Applicable glutamine

Search NIH Clinical Center for Fibrous Histiocytoma

Cochrane evidence based reviews: histiocytoma, benign fibrous

Genetic Tests for Fibrous Histiocytoma

Anatomical Context for Fibrous Histiocytoma

MalaCards organs/tissues related to Fibrous Histiocytoma:

41
Bone, Skin, Lung, Breast, Liver, Heart, Kidney

Publications for Fibrous Histiocytoma

Articles related to Fibrous Histiocytoma:

(show top 50) (show all 1423)
# Title Authors Year
1
Giant malignant fibrous histiocytoma of the testis. ( 29484233 )
2018
2
Retroperitoneal Angiomatoid Fibrous Histiocytoma Presenting as a Recurrent Spontaneous Retroperitoneal Hemorrhage in a 9-Year-Old Boy. ( 29432314 )
2018
3
Primary intracranial angiomatoid fibrous histiocytoma: a case report and literature review. ( 29540076 )
2018
4
ALK Expression in Angiomatoid Fibrous Histiocytoma: A Potential Diagnostic Pitfall. ( 29877921 )
2018
5
Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1-CREB1 fusion to the interleukin-6 receptor antibody tocilizumab. ( 29932283 )
2018
6
Giant Aneurysmal Benign Fibrous Histiocytoma (Dermatofibroma). ( 29956351 )
2018
7
Low-Grade Malignant Fibrous Histiocytoma Originating From the Medial Rectus Muscle. ( 29538190 )
2018
8
Angiomatoid Fibrous Histiocytoma With Paraneoplastic Platelet Storage Pool Deficiency. ( 29472492 )
2018
9
A subset of so-called dermal non-neural granular cell tumours are underlined by ALK fusions, further supporting the idea that they represent a variant of epithelioid fibrous histiocytoma. ( 29742298 )
2018
10
Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases. ( 29327718 )
2018
11
ALK Gene Fusions in Epithelioid Fibrous Histiocytoma: A Study of 14 Cases, With New Histopathological Findings. ( 29329131 )
2018
12
"Chondroblastoma-like" epithelioid fibrous histiocytoma: A previously undescribed and potentially confusing variant. ( 29068085 )
2018
13
Fibrous Histiocytoma of the Lacrimal Sac in an 11-Year-Old Male. ( 29494378 )
2018
14
Unusual Uptake of 131I in a Cutaneous Benign Fibrous Histiocytoma in a Patient With Thyroid Cancer. ( 29076899 )
2018
15
ESWR1-CREM Fusion in an Intracranial Myxoid Angiomatoid Fibrous Histiocytoma-Like Tumor: A Case Report and Literature Review. ( 29788195 )
2018
16
Primary Hepatic Malignant Fibrous Histiocytoma on PET/CT. ( 29485437 )
2018
17
Spindle cell predominant epithelioid fibrous histiocytoma. ( 29430713 )
2018
18
A Case of Angiomatoid Fibrous Histiocytoma Presenting as Subcutaneous Nodule in a 4-Year-Old Girl. ( 29606824 )
2018
19
Lipidized and aneurysmal fibrous histiocytoma with epithelial cysts on the left calf. ( 28225157 )
2018
20
Intracranial malignant fibrous histiocytoma. ( 29685317 )
2018
21
Fibrous histiocytoma as first presentation in systemic lupus erythematosus and sero-positive Sjögren's syndrome. ( 30094396 )
2018
22
Splenic malignant fibrous histiocytoma with concurrent hypertension and epistaxis in an Alaskan malamute dog. ( 30103739 )
2018
23
Aneurysmal fibrous histiocytoma. ( 30108116 )
2018
24
Application of 3D-printed PEEK scapula prosthesis in the treatment of scapular benign fibrous histiocytoma: A case report. ( 30123734 )
2018
25
The first ever reported case of malignant fibrous histiocytoma of the scalp. ( 30168269 )
2018
26
Treatment of angiomatoid fibrous histiocytoma after unplanned excision: a case report. ( 30170609 )
2018
27
Epithelioid Fibrous Histiocytoma: A Concise Review. ( 30289773 )
2018
28
Treatment of spinal malignant fibrous histiocytoma, a case report and literature review. ( 30527900 )
2018
29
Treatment outcomes of malignant fibrous histiocytoma of the maxillary sinus. ( 28901310 )
2017
30
Malignant fibrous histiocytoma masquerading as pyogenic granuloma. ( 28388346 )
2017
31
Primary Pulmonary Malignant Fibrous Histiocytoma. ( 29404161 )
2017
32
Primary pulmonary malignant fibrous histiocytoma: case report and literature review. ( 28932590 )
2017
33
Benign Fibrous Histiocytoma: An Uncommon Presentation. ( 28892910 )
2017
34
18F-FDG Uptake in Benign Fibrous Histiocytoma of Adrenal Gland: A Potential Pitfall. ( 28632691 )
2017
35
Deep Benign Fibrous Histiocytoma of the Anterior Mediastinum Mimicking Malignancy. ( 28497381 )
2017
36
TLE-1-Positive Angiomatoid Fibrous Histiocytoma Mimicking Synovial Sarcoma. ( 28248724 )
2017
37
Malignant fibrous histiocytoma: Database review suggests a favorable prognosis in the head and neck. ( 28988458 )
2017
38
Malignant fibrous histiocytoma in the right portion of the mandible with metastasis in pancreas. ( 29040904 )
2017
39
Angiomatoid fibrous histiocytoma of the scalp mimicking cutaneous angiosarcoma in incisional biopsy containing CD31-positive histiocytes: A potential histopathological pitfall. ( 28370384 )
2017
40
Aneurysmal Variant of Fibrous Histiocytoma- A Rare Entity Known for Recurrence. ( 28764178 )
2017
41
Malignant fibrous histiocytoma arising from renal capsule: An extremely rare entity. ( 28937382 )
2017
42
En bloc resection and prosthesis implantation to treat malignant fibrous histiocytoma of the humerus. ( 29068573 )
2017
43
Cholesterotic Fibrous Histiocytoma in a Patient with Metabolic Syndrome. ( 29033817 )
2017
44
Primary hepatic malignant fibrous histiocytoma combined with invasion of inferior vena cava: A case report and literature review. ( 28591058 )
2017
45
Retrovesical malignant fibrous histiocytoma: a rare tumor. ( 29197849 )
2017
46
CORR Insights(Ar): Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma. ( 28656494 )
2017
47
Pathologically Benign Lymph Nodes Can Mimic Malignancy on Imaging in Patients With Angiomatoid Fibrous Histiocytoma. ( 28536856 )
2017
48
Aneurysmal fibrous histiocytoma - spindle cell tumour with pigment: A diagnostic dilemma on cytology. ( 28727241 )
2017
49
Dermoscopy and reflectance confocal microscopy of osteoclastic deep benign fibrous histiocytoma. ( 28895663 )
2017
50
Intracranial myxoid mesenchymal tumors with EWSR1-CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity? ( 28281318 )
2017

Variations for Fibrous Histiocytoma

Expression for Fibrous Histiocytoma

Search GEO for disease gene expression data for Fibrous Histiocytoma.

Pathways for Fibrous Histiocytoma

Pathways related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.53 ATF1 EWSR1 FUS MITF
2 11.19 ACTC1 DES VIM
3 10.54 ATF1 CREB1
4 10.34 ATF1 CREB1 MITF

GO Terms for Fibrous Histiocytoma

Cellular components related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 blood microparticle GO:0072562 8.8 ACTC1 F13A1 SERPINA3

Biological processes related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 intermediate filament organization GO:0045109 8.96 DES VIM
2 muscle filament sliding GO:0030049 8.8 ACTC1 DES VIM

Molecular functions related to Fibrous Histiocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 9.17 ATF1 CREB1 DES EWSR1 FUS S100B
2 transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding GO:0003705 9.13 ATF1 CREB1 MITF

Sources for Fibrous Histiocytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....